pharmaceuticals
pharmaceuticals Articles
It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and political oversight can still be...
Published:
Last Updated:
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Published:
Last Updated:
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Published:
Last Updated:
With earnings this positive and shares responding as a result, investors have to wonder if Valeant Pharmaceuticals is for real this time, or is this just a head fake.
Published:
Last Updated:
Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter financial results. The company said that it had $0.21 in EPS and $220.9...
Published:
Last Updated:
JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is companies that have strong new product cycles already in motion.
Published:
Last Updated:
Shares of Pieris Pharmaceuticals saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration with AstraZeneca.
Published:
Last Updated:
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Following the closing of the sale of three skincare brands to L'Oréal and after the closing of the divestiture of a manufacturing facility in Brazil, Valeant said that it now has further reduced its...
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Shares of Immune Pharmaceuticals saw an incredible gain in Thursday’s session following the announcement of an exclusive license agreement.
Published:
Last Updated:
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
Published:
Last Updated:
Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares of its common stock.
Published:
Last Updated:
When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and biotech companies can see harsh punishment.
Published:
Last Updated: